HIV and AIDS Trial, Recruiting NCT06088277 Sponsor: Boston University Condition: HIV and AIDS
Back to Hiv Aids

HIV and AIDS Trial, Recruiting

NCT06088277
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are willing to give their agreement to participate and sign a consent form through an online system called REDCap
  • People who are willing to follow all study steps and are available for the full length of the study
  • People who can read in English or Spanish
  • People who are current patients at one of the participating community health centres (dental clinics)
  • People who have at least one of the following risk factors for HIV: men who have sex with men, having multiple sexual partners, or using intravenous (injected) drugs

Who may not be able to join:

  • People who already have HIV
  • People who are currently taking part in another HIV study or another study involving text messages
  • Women who report having sexual contact only with other women
  • People who do not have a mobile phone or other device that can receive text messages from a service called Agile Health
  • People whose mobile phone plan does not include unlimited text messaging
  • People who have not sent or received any text messages at least once in the past month
  • People who score 2 or below on a short reading ability screening question

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Michelle Henshaw, DDS, MPH, Boston University Goldman School of Dental Medicine

Phone: :617-358-6111

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Boston University
Registry
ClinicalTrials.gov
Start date
16 August 2024
Est. completion
14 April 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of participants that obtain HIV testing

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov